1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
TerrAscend Corp.

TerrAscend Corp.

TSND.TO
TerrAscend Corp.CA flagToronto Stock Exchange
0.84
CAD
- -
- -
260.03MMarket Cap
TerrAscend Corp.
TSND.TO
(Toronto Stock Exchange)

Recent

price

0.84

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
0.05
0.64
0.88
1.07
1.01
0.9
0.92
0.87
0.86
Revenue per Share
-0.02
-0.15
-0.17
-1.61
-0.93
0.07
-1.24
-0.34
-0.28
-0.29
-0.27
Basic EPS, GAAP
-0.01
-0.41
-0.3
-0.74
-0.54
-0.4
-0.28
0.06
0.1
0.04
0.05
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.06
0.91
0.27
0.11
-2.13
-1.74
-2.53
-2.52
-2.67
-2.87
-2.87
Book Value per Share
0.06
1.47
0.44
-1.27
-1.31
-0.16
-0.04
-0.29
-0.34
-0.59
-0.65
Tangible Book Value per Share
27
36
94
100
150
181
244
279
292
301
305
Basic Weighted Avg Shares
- -
- -
5
64
132
194
248
251
268
261
262
Sales/Revenue/Turnover
- -
- -
-396.92
-73.64
15.82
16.41
-1.6
19.95
15.43
17.13
16.77
Operating Margin (%)
- -
- -
1
6
13
14
25
16
16
17
17
Depreciation Expense
-1
-5
-16
-161
-139
13
-304
-96
-80
-86
-82
Net Income, GAAP
- -
- -
- -
- -
- -
64.85
- -
- -
592.36
592.04
525.81
Effective Tax Rate (%)
- -
- -
-322.71
-251.78
-105.34
6.5
-122.65
-38.14
-29.93
-33.09
-31.21
Profit Margin (%)
1
41
21
-41
2
106
-16
-104
86
30
35
Working Capital
- -
- -
- -
30
200
202
184
115
223
239
242
LT Debt
2
54
43
58
-13
229
321
241
177
99
91
Total Equity
- -
- -
- -
- -
- -
3.35
- -
- -
-44.24
-56.42
-48.6
Return on Invested Capital (%)
- -
- -
- -
- -
- -
-17.89
- -
- -
51.5
46.74
42.41
Return on Capital (%)
- -
-31.28
-55.55
-897.34
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
12
17
12
LT Borrowings
212
211
212
LT Finance Leases
31
29
30
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
307
309
308
Market Capitalization
347
297
271

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
119
110
102
Cash, Cash Equivalents & STI
38
38
39
Accounts Receivable, Net
16
15
14
Inventories
34
34
36
Total Current Liabilities
76
80
68
Payables & Accruals
45
45
44
ST Debt
12
17
12
Deferred Revenue
4
4
4

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-374.94%
-44%
Free Cash Flow
- -
-27.22%
-59.27%
Net Income, GAAP
- -
-538.61%
7.47%
Sales/Revenue/Turnover
- -
15.97%
-2.81%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
81
67
65
74
268
2025
64
65
65
66
261
2026
66
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.06
-0.03
-0.08
- -
-0.28
2025
-0.05
-0.17
-0.08
- -
-0.29
2026
-0.03
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Anxo Pharmaceutical Co., Ltd. (6677.TWO)
Jubilant Pharmova Limited (JUBLPHARMA.NS)
Molecule Holdings Inc. (EVRRF)
Hempfusion Wellness Inc. (CBDHF)
Standard Chem & Pharm Co. Ltd. (1720.TW)
Nichi-Iko Pharmaceutical Co., Ltd. (NHKFF)
Business
TerrAscend Corp. is a prominent North American cannabis operator, actively engaged in the cultivation, processing, and distribution of cannabis products across key markets in the United States and Canada. The company manages vertically integrated operations spanning California, Maryland, New Jersey, Ohio, and Pennsylvania, complemented by retail presence in Canada. Its diverse product portfolio caters to both medical and adult-use consumers, featuring offerings such as flower, vaporizables, concentrates, tinctures, topicals, and edibles. Operating a network of retail dispensaries, including the acclaimed Apothecarium brand, TerrAscend emphasizes consistent quality and patient education. The company strategically manages an array of synergistic brands and businesses, among them Gage Cannabis, Kind Tree, Legend, Valhalla Confections, State Flower, Ilera Healthcare, Wana, Cookies, Lemonnade, and Ratio Cannabis. Recent strategic initiatives include expanding its footprint in emerging markets like Ohio through acquisitions, and bolstering its presence in New Jersey. TerrAscend has demonstrated consistent financial strength, reporting positive operating cash flow for thirteen consecutive quarters. The company, founded in 2017, is headquartered in Mississauga, Canada, with operational offices in King of Prussia, Pennsylvania.

Company News

APIChatGPT

  • globenewswire.com

    TerrAscend Reports First Quarter 2026 Financial Results

  • globenewswire.com

    TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call